Tag: U.S. Food and Drug Administration (FDA)
During the Sept. 17 meeting of the FDA advisory panel to recommend whether to approve the third dose of Pfizer’s COVID vaccine, physicians pointed to data they said to confirm the risks of Pfizer’s COVID vaccine don’t outweigh the benefits. #vaccineboosters
In a paper published in the Lancet, experts warned there could be risks to boosters if they are widely introduced too soon, or too frequently, especially with vaccines that can have immune-mediated side effects.
Buried in the fine print of Monday’s approval by the U.S. Food and Drug Administration of the Pfizer Comirnaty COVID vaccine are two critical facts that affect whether the vaccine can be mandated, and whether Pfizer can be held liable for injuries. #pfizerapproval
FDA Grants Full Approval of Pfizer Vaccine, Critics Blast Agency for Lack of Data, Scientific Debate
Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data. #PfizerVaccine
Many Americans first started to learn about ivermectin in December 2020 when Dr. Pierre Kory testified in front of the Homeland Security Committee and gave an impassioned testimony about the medicine as a treatment for COVID-19 #ivermectin
VAERS data released Friday by the CDC showed a total of 571,831 reports of adverse events from all age groups following COVID vaccines, including 12,791 deaths and 77,490 serious injuries between Dec. 14, 2020, and Aug. 6, 2021. Yet the U.S. Food and Drug Administration (FDA) on Aug. 12 authorized the third dose of Pfizer-BioNTech and Moderna COVID vaccines for people with compromised immune systems. #covidvaccine #VAERS
The U.S. Food and Drug Administration authorized a third COVID shot for immunocompromised patients. The Pfizer and Moderna vaccines have not been fully approved, and neither company has completed late-stage clinical trials proving a third dose will work. #covidboostershot #covidvaccine #covidbooster
A few weeks ago, we told you about the FDA’s recent actions threatening NAC supplements—products that the FDA has allowed on the market for decades. #fdacorrupt
Pfizer met with U.S. regulators Monday evening to press its case for quick authorization of COVID booster vaccines but health officials, who remained unconvinced, called for more data. #covidboostershot #covidvaccine #covidbooster
The U.S. Food and Drug Administration will announce a new warning on Johnson & Johnson’s COVID vaccine saying the shot is linked to Guillain–Barré syndrome. In April, the agency added a warning about blood clotting disorders to the J&J shot. #vaccinedangers #covidvaccine
U.S. federal health agencies and the maker of one of the most popular COVID vaccines are publicly at odds over whether fully vaccinated people will soon need a third booster shot. #covidvaccine #covidbooster
Thanks to user fees drug companies pay the FDA, the number and speed of drug approvals have been increasing over time — so have the number of drugs that end up having serious safety issues. #pharmacorrupt
The authors (two physicians and a professor) argue that Emergency Use Authorization for mass child vaccination presents a different balance of risks and benefits than it did for adults. #kidvaccines
Spending on pharmaceutical industry lobbying also reached a record amount in 2020, at more than $306 million, compared to $299 million in 2019 #BigPharma #lobbying
As reports surfaced today of yet another healthcare worker who suffered a severe allergic reaction to Pfizer’s COVID vaccine, it’s time the FDA and Fauci explain what they plan to do about it. #covidvaccine
